Overview
Xellar is an AI drug discovery platform.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $10M (Angel), Aug 30, 2022.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Aug 30, 2022 | $10M · Angel | 君联资本, 真格基金, 雅亿资本 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Aug 30, 2022 | — · Angel | 君联资本, 真格基金, 雅亿资本 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
器官芯片、高内涵三维细胞成像与 AI 药物发现平台 耀速科技是一家AI药物发现平台